Germline control of anti-tumour immunity

被引：0
|
作者：
Harjes, Ulrike
机构：
[1] Nature Reviews Cancer,
来源：
NATURE REVIEWS CANCER | 2020年 / 20卷 / 08期
关键词：
D O I：
10.1038/s41568-020-0282-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ostendorf et al. show that germline variants of humanAPOEplay a role in melanoma that is opposite to that in Alzheimer disease, withAPOE4carrier status being associated with reduced melanoma growth in mice and improved outcome in patients with advanced melanoma.
引用
收藏
页码：414 / 414
页数：1
相关论文
共 50 条
  • [41] Small polymeric nanoparticles drive potent anti-tumour immunity
    Ward, Ross William
    Wolf, Natalia Munoz
    Lavelle, Ed C.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 392 - 392
  • [42] Improved Anti-Tumour Adaptive Immunity Can Overcome the Melanoma Immunosuppressive Tumour Microenvironment
    Dang, Nana
    Waer, Mark
    Sprangers, Ben
    Lin, Yuan
    [J]. CANCERS, 2019, 11 (11)
  • [43] STING signalling compensates for low tumour mutation burden to drive anti-tumour immunity
    Tan, Jiay
    Egelston, Colt A.
    Guo, Weihua
    Stark, Jeremy M.
    Leea, Peter P.
    [J]. EBIOMEDICINE, 2024, 101
  • [44] CDK4/6 inhibition triggers anti-tumour immunity
    Shom Goel
    Molly J. DeCristo
    April C. Watt
    Haley BrinJones
    Jaclyn Sceneay
    Ben B. Li
    Naveed Khan
    Jessalyn M. Ubellacker
    Shaozhen Xie
    Otto Metzger-Filho
    Jeremy Hoog
    Matthew J. Ellis
    Cynthia X. Ma
    Susanne Ramm
    Ian E. Krop
    Eric P. Winer
    Thomas M. Roberts
    Hye-Jung Kim
    Sandra S. McAllister
    Jean J. Zhao
    [J]. Nature, 2017, 548 : 471 - 475
  • [45] Gut bacteria modulate anti-tumour immunity in patients with hepatocellular carcinoma
    Devshi, Dhruti
    Phillips, Sandra
    Edwards, Helen
    Harris, Nicola
    Preziosi, Melissa
    Suddle, Abid
    Riva, Antonio
    Chokshi, Shilpa
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S639 - S639
  • [46] ANTI-TUMOUR IMMUNITY BY NORMAL ALLOGENEIC BLOOD-TRANSFUSION IN RAT
    OIKAWA, T
    HOSOKAWA, M
    IMAMURA, M
    SENDO, F
    NAKAYAMA, M
    GOTOHDA, E
    KODAMA, T
    KOBAYASHI, H
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1977, 27 (03): : 549 - 554
  • [47] TGFβ1-specific antibody spurs anti-tumour immunity
    Megan Cully
    [J]. Nature Reviews Drug Discovery, 2020, 19 : 310 - 310
  • [48] Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
    Spranger, Stefani
    Bao, Riyue
    Gajewski, Thomas F.
    [J]. NATURE, 2015, 523 (7559) : 231 - U261
  • [49] CDK4/6 inhibition triggers anti-tumour immunity
    Goel, Shom
    DeCristo, Molly J.
    Watt, April C.
    BrinJones, Haley
    Sceneay, Jaclyn
    Li, Ben B.
    Khan, Naveed
    Ubellacker, Jessalyn M.
    Xie, Shaozhen
    Metzger-Filho, Otto
    Hoog, Jeremy
    Ellis, Matthew J.
    Ma, Cynthia X.
    Ramm, Susanne
    Krop, Ian E.
    Winer, Eric P.
    Roberts, Thomas M.
    Kim, Hye-Jung
    McAllister, Sandra S.
    Zhao, Jean J.
    [J]. NATURE, 2017, 548 (7668) : 471 - +
  • [50] CELL-MEDIATED ANTI-TUMOUR IMMUNITY IN PATIENTS WITH GENITOURINARY MALIGNANCY
    BHATTI, RA
    ABLIN, RJ
    GUINAN, PD
    RIOS, E
    FLANAGAN, M
    MCKIEL, CF
    [J]. CLINICAL RESEARCH, 1976, 24 (04): : A548 - A548
12345